ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea · Delayed Price · Currency is KRW 2,010.00
0.00 (0.00%)
At close: Jun 30, 2026
ENBIO Market Cap
ENBIO has a market cap or net worth of 21.84 billion as of June 30, 2026. Its market cap has decreased by -22.54% in one year.
Market Cap
21.84B
Enterprise Value
38.77B
Revenue
34.26B
Ranking
n/a
PE Ratio
27.38
Stock Price
2,010.00
Market Cap Chart
Since December 11, 2020, ENBIO's market cap has decreased from 123.03B to 21.84B, a decrease of -82.24%. That is a compound annual growth rate of -26.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 21.84B | -11.65% |
| Dec 30, 2025 | 24.72B | 12.62% |
| Dec 30, 2024 | 21.95B | -42.37% |
| Dec 28, 2023 | 38.09B | -17.82% |
| Dec 29, 2022 | 46.35B | -46.35% |
| Dec 30, 2021 | 86.40B | -45.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moorim SP | 22.23B |
| PC Direct | 22.16B |
| Abpro Bio | 22.15B |
| CU Medical Systems | 21.95B |
| Hurum | 21.93B |
| Plateer | 21.89B |
| AUTO& | 21.85B |
| MOA Life Plus | 21.59B |